Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028

Report Code : TIPRE00029530 | Region : Global | Industry : Food and Beverages | Published Date : 30/Jul/2022
Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)

The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Probiotics are live micro-organisms that promote good digestive health and help to improve human gut health. They play a vital role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Gut health has become one of the prime health concerns among consumers. Increasing awareness regarding the benefits of probiotics has surged their popularity in infant, child, and maternal women health supplements. These factors are significantly driving the demand for these supplements across the world. There is a rising prevalence of digestive disorders due to unhealthy consumption habits amongst children. This factor provides a strong potential to the infant, child, and maternal probiotic supplements market.

Based on end use, the infant, child, and maternal probiotic supplements market is segmented into infant and toddler, children, and maternal women. The children segment accounted for the largest market share in 2020. However, the maternal women segment is expected to register the highest CAGR during the forecast period.

Probiotic supplements are gaining popularity among pregnant women due to their role in reducing the risk of eczema in babies, lessening complications associated with childbirth, and improving the metabolic health of expectant mothers. Women experience dramatic changes in physiology and immune systems during pregnancy, including alterations in the gut microbiome population. These issues can be addressed using probiotic supplements. Probiotic supplements help pregnant women gain weight.

Based on region, the infant, child, and maternal probiotic supplements market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2020, North America held the largest market share. Asia Pacific is estimated to register the fastest CAGR over the forecast period. The dominance of North America is attributed to the increasing awareness among consumers about the benefits of probiotic supplements for infants, children, and pregnant women. Parents in the region are more concerned about their children's development and growth.

Some common health conditions observed in the region include allergies, asthma, urinary tract infection, colic in infants, and autism. According to the Allergy & Asthma Foundation of Asthma, in 2018, approximately 5.2 thousand children in the US were diagnosed with seasonal allergic rhinitis. Increasing health issues among children have concerned parents, which in turn, has resulted in the rising uptake of probiotic supplements.

Moreover, governments of North American countries are taking initiatives to improve infant and children's health. For instance, Healthy Start is one initiative to improve childhood health care. This initiative is designed to reduce the infant mortality rate and improve prenatal health in the region. Hence, the prenatal and postnatal use of probiotic supplements is further surging the growth of the infant, child, and maternal probiotic supplements market across North America.

The key players operating in the infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy's Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies are focusing on new product launches and geographical expansions to meet the growing consumer demand worldwide.

The overall infant, child, and maternal probiotic supplements market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, national sales managers, and external consultants, such as valuation experts, research analysts, and key opinion leaders, specializing in the Infant, Child, and Maternal Probiotic Supplements Market.

The List of Companies - Infant, Child, and Maternal Probiotic Supplements Market

1. Bayer Corporation

2. Nestle S.A.

3. Mommy’s Bliss Inc.

4. LoveBug Probiotics

5. Biogaia AB

6. MaryRuth Organics, LLC

7. Pharmavite LLC

8. Evolve Biosystems

9. Biomeology

10. Nordic Naturals

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

3.1 Scope of the Study

3.2 Research Methodology

3.2.1 Data Collection:

3.2.2 Primary Interviews:

3.2.3 Hypothesis Formulation:

3.2.4 Macro-economic Factor Analysis:

3.2.5 Developing Base Number:

3.2.6 Data Triangulation:

3.2.7 Country Level Data:

3.2.8 Limitations and Assumptions:

4. Infant, Child, and Maternal Probiotic Supplements Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers

4.2.2 Bargaining Power of Buyers

4.2.3 Threat of New Entrants

4.2.4 Competitive Rivalry

4.2.5 Threat of Substitutes

4.3 Expert Opinion

4.4 Ecosystem Analysis

5. Infant, Child, and Maternal Probiotic Supplements Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition

5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women

5.2 Market Restraints

5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn

5.3 Market Opportunities

5.3.1 Surging Demand in Developing Regions

5.4 Future Trends

5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space

5.5 Impact Analysis of Drivers and Restraints

6. Infant, Child, and Maternal Probiotic Supplements – Global Market Analysis

6.1 Infant, Child, and Maternal Probiotic Supplements Market Overview

6.2 Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)

6.3 Competitive Positioning – Key Market Players

7. Infant, Child, And Maternal Probiotic Supplements Market Analysis – By Form

7.1 Overview

7.2 Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)

7.3 Capsules and Softgels

7.3.1 Overview

7.3.2 Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

7.4 Gummies

7.4.1 Overview

7.4.2 Gummies: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

7.5 Liquid:

7.5.1 Overview

7.5.2 Liquid: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

7.6 Others

7.6.1 Overview

7.6.2 Others: Infant, Child, And Maternal Probiotic Supplements Market– Revenue and Forecast to 2028 (US$ Thousand)

8. Infant, Child, And Maternal Probiotic Supplements Market Analysis – By End User

8.1 Overview

8.2 Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)

8.3 Infant and Toddler

8.3.1 Overview

8.3.2 Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

8.4 Children

8.4.1 Overview

8.4.2 Children: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

8.5 Maternal Women

8.5.1 Overview

8.5.2 Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9. Infant, Child, and Maternal Probiotic Supplements Market – Geographic Analysis

9.1 Overview

9.2 North America: Infant, Child, and Maternal Probiotic Supplements Market

9.2.1 North America: Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)

9.2.2 North America: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.2.3 North America: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.2.4 North America: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country

9.2.4.1 US: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.2.4.1.1 US: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.2.4.1.2 US: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.2.4.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.2.4.2.1 Canada: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.2.4.2.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.2.4.3 Mexico: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.2.4.3.1 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.2.4.3.2 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market

9.3.1 Europe: Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)

9.3.2 Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.3.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.3.4 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country

9.3.4.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.3.4.1.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.3.4.1.2 Germany: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.3.4.2 UK: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.3.4.2.1 UK: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.3.4.2.2 UK: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.3.4.3 France: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.3.4.3.1 France: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.3.4.3.2 France: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.3.4.4 Italy: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.3.4.4.1 Italy: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.3.4.4.2 Italy: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.3.4.5 Russia: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.3.4.5.1 Russia: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.3.4.5.2 Russia: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.3.4.6 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)

9.3.4.6.1 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form

9.3.4.6.2 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market

9.4.1 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.4.2 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.4.3 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.4.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country

9.4.4.1 China: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.4.4.1.1 China: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.4.4.1.2 China: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.4.4.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.4.4.2.1 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.4.4.2.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.4.4.3 Australia: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.4.4.3.1 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.4.4.3.2 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.4.4.4 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.4.4.4.1 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.4.4.4.2 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.4.4.5 Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.4.4.5.1 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.4.4.5.2 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.5 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market

9.5.1 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.5.2 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.5.3 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.5.4 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Key Region

9.5.4.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.5.4.1.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.5.4.1.2 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by End User

9.5.4.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)

9.5.4.2.1 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by Form

9.5.4.2.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by End User

10. Industry Landscape

10.1 Overview

10.2 Product launch

10.3 Expansion

11. Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market

11.1 Impact of COVID-19 on Infant, Child, and Maternal Probiotic Supplements Market

11.2 North America: Impact Assessment of COVID-19 Pandemic

11.3 Europe Impact Assessment of COVID-19 Pandemic

11.4 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11.6 South & Central America: Impact Assessment of COVID-19 Pandemic

12. COMPANY PROFILES

12.1 Bayer Corporation

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 MaryRuth Organics, LLC

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Mommy’s Bliss Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Pharmavite LLC

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Nestlé S.A.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 BioGaia AB

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Evolve Biosystems

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Lovebug Probiotics

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Biomeology

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Nordic Naturals

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Word Index

LIST OF TABLES.

Table 1. Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)

Table 2. Global Infant, Child, And Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 3. Global Infant, Child, And Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 4. North America Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 5. North America Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 6. US Infant, Child, and Maternal Probiotic Supplements Market, Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 7. US Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 8. Canada Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 9. Canada Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 10. Mexico Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 11. Mexico Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 12. Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 13. Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 14. Germany Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 15. Germany Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 16. UK Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 17. UK Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 18. France Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 19. France Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 20. Italy Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 21. Italy Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 22. Russia Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 23. Russia Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 24. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 25. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 26. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 27. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 28. China Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 29. China Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 30. Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 31. Japan Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 32. Australia Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 33. Australia Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 34. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 35. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 36. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 37. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 38. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 39. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 40. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 41. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 42. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)

Table 43. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 44. List of Abbreviation

The List of Companies - Infant, Child, and Maternal Probiotic Supplements Market

1. Bayer Corporation

2. Nestle S.A.

3. Mommy’s Bliss Inc.

4. LoveBug Probiotics

5. Biogaia AB

6. MaryRuth Organics, LLC

7. Pharmavite LLC

8. Evolve Biosystems

9. Biomeology

10. Nordic Naturals

Reason To Buy

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in the global infant, child, and maternal probiotic supplements market, thereby allowing players to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

CHOOSE LICENCE TYPE
(Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028)
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
TOP
Quick Enquiry